Login / Signup

In silico discovery of terpenoid metabolism in Cannabis sativa.

Luca Massimino
Published in: F1000Research (2017)
Due to their efficacy, cannabis based therapies are currently being prescribed for the treatment of many different medical conditions. Interestingly, treatments based on the use of cannabis flowers or their derivatives have been shown to be very effective, while therapies based on drugs containing THC alone lack therapeutic value and lead to increased side effects, likely resulting from the absence of other pivotal entourage compounds found in the Phyto-complex. Among these compounds are terpenoids, which are not produced exclusively by cannabis plants, so other plant species must share many of the enzymes involved in their metabolism. In the present work, 23,630 transcripts from the canSat3 reference transcriptome were scanned for evolutionarily conserved protein domains and annotated in accordance with their predicted molecular functions. A total of 215 evolutionarily conserved genes encoding enzymes presumably involved in terpenoid metabolism are described, together with their expression profiles in different cannabis plant tissues at different developmental stages. The resource presented here will aid future investigations on terpenoid metabolism in Cannabis sativa.
Keyphrases
  • healthcare
  • transcription factor
  • genome wide
  • small molecule
  • high throughput
  • current status
  • amino acid
  • combination therapy
  • genome wide identification
  • smoking cessation
  • replacement therapy
  • drug induced
  • cell wall